Shuwen Biotech Receives CE Mark for EGFR Mutation PCR Kit for Lung Cancer

Oncology, Respiratory September 19, 2017 at 10:13 AM 0 comments

Deqing, China, 18 September, 2017 – Shuwen Biotech announced today that it has received CE-IVD marking for its EGFR real time PCR detection kit allowing the company to market its kit in countries that recognize the designation. The CE Marked kit showcases Shuwen’s strengthening research and development capabilities which ultimatelyRead More

RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.

Gastroenterology, Oncology September 19, 2017 at 10:11 AM 0 comments

Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI) indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions PPIs are one of the most commonly prescribed classes of medications in the U.S., with an estimated marketRead More

Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017

Hematology September 11, 2017 at 8:36 AM 0 comments

Hamburg, Germany, 08 September, 2017 – Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology is pleased to announce new data from a large real-world prospective evaluation of the OncoBEAM™ RAS CRC test for routine clinicalRead More

Congenica’s Sapientia™ Selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project

Uncategorized September 6, 2017 at 10:57 AM 0 comments

Cambridge, UK, 06 September, 2017 – Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portugal and part of the Coimbra Hospital and University Centre (CHUC). Through this partnership, the hospital has licensedRead More

AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round

Uncategorized September 5, 2017 at 1:54 PM 0 comments

Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund Funds will be used to support: Clinical development of lead vaccine (ATP128) for colorectal cancer through to clinical proof-of-concept Further development of KISIMA technology platform for therapeutic tumour vaccination Geneva, Switzerland, 05 September, 2017 – AMAL TherapeuticsRead More

Introducing the European Medical Journal 2.3

Introducing the European Medical Journal 2.3

Uncategorized August 31, 2017 at 8:30 AM 0 comments

United Kingdom, August 31, 2017: Welcome to this year’s third instalment of the European Medical Journal. The issue contains an abundance of high-quality, peer-reviewed articles from a variety of medical fields, including oncology, cardiology, urology, and haematology. Haematologists in particular will not want to miss this edition, as it containsRead More

Philips supports global transformation of pathology with two new fully digitized labs in Austria

Uncategorized August 30, 2017 at 11:45 AM 0 comments

With availability for primary diagnostic use in North America, Europe and Asia, Philips IntelliSite Pathology Solution is helping labs worldwide to improve the efficiency and quality of cancer diagnostics. Amsterdam, 29 August, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the continued momentum of its cutting-edgeRead More

Study Results: Titanium-Nitride-Oxide (TiNO) Coated Stent Is Non-Inferior to Bioabsorbable Polymer Everolimus-Eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

Uncategorized August 30, 2017 at 11:42 AM 0 comments

Barcelona, 29 August, 2017 – During the Late Breaking Science session at the European Society of Cardiology (ESC) Congress in Barcelona, Dr. Pim Tonino (interventional cardiologist, Heart center Catharina Hospital, Eindhoven, the Netherlands) presented study results comparing TiNO coated stents (OPTIMAXTM from Hexacath, Paris, France) versus EES (SYNERGYTM from BostonRead More

Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse

Oncology August 24, 2017 at 10:30 AM 0 comments

Houston, Texas, USA and Tuebingen, Germany, 21 August, 2017 – Immatics, a leading company in the field of cancer immunotherapy, today announced that it has initiated enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101, using its proprietary ACTolog® approach. The IMA101 phaseRead More

Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency

Uncategorized August 24, 2017 at 10:27 AM 0 comments

London, UK, 22 August, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies for patients with severe inherited orphan diseases, today announces that the UK Medicines and Healthcare Products Regulatory Agency (“MHRA”) granted a Promising Innovative Medicine Designation to OTL-101, its lead programme for theRead More